Barclays raised the firm’s price target on Illumina (ILMN) to $90 from $85 and keeps an Underweight rating on the shares. The firm believes Illumina’s quarter did little to change the “entrenched bull/bear debate.”
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ILMN:
- Illumina’s Strategic Concerns and Uncertain Outlook: Sell Rating Reiterated with Lowered Price Objective
- Illumina’s Q2 2025 Earnings and Strategic Moves
- Hold Rating on Illumina Amid Strong Performance and Market Challenges
- Closing Bell Movers: Apple up 2%, Amazon down over 6% after results
- Illumina raises FY25 adjusted EPS view to $4.45-$4.55 from $4.20-$4.30